Our results with VEGF are in accordance with the hypothesis that, when monitoring the efficacy of cytotoxic therapy, a substantial decrease in the levels of tumor marker often correlates with response to therapy whereas an increase or an insufficient decrease are generally associated with no response or disease progression. Here, VEGFA is linked to neoplasm.